Hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure

Active Ingredient: Human hepatitis B immunoglobulin

Indication for Human hepatitis B immunoglobulin

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Therapeutic intent: Preventive action

For this indication, competent medicine agencies globally authorize below treatments:

10,000 IU on the day of transplantation and thereafter 2,000-10,000 IU once dailt for 7 days

For:

Route of admnistration

Intravenous

Defined daily dose

2,000 - 10,000 [iU]

Dosage regimen

From 2,000 To 10,000 [iU] once every day for 7 day(s)

Loading dose

10,000 [iU]

Maintenance dose

2,000 [iU]

Detailed description

10 000 IU on the day of transplantation, peri-operatively, then 2000-10 000 IU (40-200 ml)/day for 7 days, and as necessary to maintain antibody levels above 100-150 IU/l in HBV-DNA negative patients and above 500 IU/l in HBV-DNA positive patients.

Dosage considerations

Human hepatitis B immunoglobulin solution should be infused intravenously at an initial rate of 0.1 ml/kg/hr for 10 minutes. In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped. If well tolerated, the rate of administration may gradually be increased to a maximum of 1 ml/kg/hr.

10.000 IU/1,73 m²

For:

Route of admnistration

Intravenous

Defined daily dose

10,000 - 10,000 [iU] per m² of body surface area (BSA)

Dosage regimen

From 10,000 To 10,000 [iU] per m² of body surface area (BSA) once every day

Detailed description

Posology should be adjusted according to body surface area, on the basis of 10000 IU/1.73 m².

Dosage considerations

Human hepatitis B immunoglobulin solution should be infused intravenously at an initial rate of 0.1 ml/kg/hr for 10 minutes. In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped. If well tolerated, the rate of administration may gradually be increased to a maximum of 1 ml/kg/hr.

Active ingredient

Human hepatitis B immunoglobulin

Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure.

Read more about Human hepatitis B immunoglobulin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.